PJP holdings — Invesco Pharmaceuticals ETF
Invesco Pharmaceuticals ETF (PJP) held 33 positions with net assets of $472M as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 53.7% of the fund, led by Invesco Private Prime Fund, ABT, ABBV.
PJP top holdings
- Invesco Private Prime Fund — 7.93% ($37.4M)
- ABT Abbott Laboratories — 5.67% ($26.8M)
- ABBV AbbVie Inc. — 5.48% ($25.9M)
- AMGN Amgen Inc. — 5.33% ($25.2M)
- JNJ Johnson & Johnson — 5.18% ($24.4M)
- MRK Merck & Co., Inc. — 5.06% ($23.9M)
- LLY Eli Lilly and Co. — 5.02% ($23.7M)
- CORT Corcept Therapeutics Inc. — 4.96% ($23.4M)
- GILD Gilead Sciences, Inc. — 4.53% ($21.4M)
- PFE Pfizer Inc. — 4.50% ($21.2M)
- AMRX Amneal Pharmaceuticals, Inc. — 3.75% ($17.7M)
- Invesco Private Government Fund — 3.73% ($17.6M)
- LQDA Liquidia Corp. — 3.66% ($17.3M)
- TVTX Travere Therapeutics, Inc. — 3.30% ($15.6M)
- LGND Ligand Pharmaceuticals Inc. — 3.20% ($15.1M)
- REGN Regeneron Pharmaceuticals, Inc. — 3.14% ($14.8M)
- HRMY Harmony Biosciences Holdings, Inc. — 3.06% ($14.5M)
- BMY Bristol-Myers Squibb Co. — 2.94% ($13.9M)
- VTRS Viatris Inc. — 2.83% ($13.3M)
- JAZZ Jazz Pharmaceuticals PLC — 2.79% ($13.2M)
- BIIB Biogen Inc. — 2.75% ($13.0M)
- COLL Collegium Pharmaceutical, Inc. — 2.74% ($12.9M)
- PBH Prestige Consumer Healthcare Inc. — 2.74% ($12.9M)
- OCUL Ocular Therapeutix, Inc. — 2.58% ($12.2M)
- ANIP ANI Pharmaceuticals, Inc. — 2.55% ($12.0M)
What are PJP's top 10 holdings?
Invesco Private Prime Fund (7.9%), ABT (5.7%), ABBV (5.5%), AMGN (5.3%), JNJ (5.2%), MRK (5.1%), LLY (5.0%), CORT (5.0%), GILD (4.5%), PFE (4.5%).
How many stocks are in PJP?
Invesco Pharmaceuticals ETF reported 33 holdings as of July 31, 2026.